Universal Health Services (UHS) has drawn investor attention after its share price closed at US$168.64. The stock has declined over the past month and past 3 months despite recent growth in revenue.

Recent moves show momentum has softened, with the share price down 7.55% over the past 30 days and 28.27% over 90 days, while the 3 year total shareholder return of 26.42% still reflects a much stronger longer term outcome.

If this healthcare stock has you reassessing where growth could come from next, it might be worth scanning for other potential opportunities using our list of 28 healthcare AI stocks

With Universal Health Services shares under pressure despite revenue growth and a value score of 6, the key question is whether this healthcare stock is trading at a discount or whether the market is already pricing in its future growth.

Most Popular Narrative: 24.9% Undervalued

According to the most followed narrative, Universal Health Services has a fair value of $224.48 compared with the last close at $168.64, pointing to a sizeable valuation gap that rests heavily on its role in behavioral healthcare.

UHS operates one of the largest behavioral health hospital networks in the country, alongside a substantial acute care segment. That dual exposure gives the company a stabilizing balance: acute care supports cash flow consistency, while behavioral health provides structural growth driven by demographics, policy shifts, and unmet clinical need. Over time, this combination has proven resilient across economic cycles, making UHS a frequent reference point when investors look for defensiveness paired with growth.

Want to see how this narrative gets to that higher fair value? It leans heavily on behavioral health demand, margin resilience, and a future earnings profile that treats UHS more like a compounder than a slow grower.

Result: Fair Value of $224.48 (UNDERVALUED)

However, this depends on continued behavioral health demand and stable reimbursement. Any sustained pressure on margins or earnings expectations could quickly challenge that undervaluation narrative.

Next Steps

With mixed sentiment around risk and reward, now is a good time to look through the numbers yourself, weigh both sides, and see whether the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you could miss other compelling setups that better fit your risk, income, or value goals, so broaden your search now.

• Spot potential high-upside opportunities early by checking out 28 elite penny stocks with strong financials that combine smaller size with stronger financial profiles.
• Strengthen your core holdings by reviewing 51 high quality undervalued stocks that pair solid fundamentals with prices that still look reasonable.
• Dial back risk without abandoning growth by focusing on 66 resilient stocks with low risk scores that score well on financial resilience and consistency.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.